NewsBenzingaTranscripción de la llamada de resultados del tercer trimestre de 2026 de Avery Dennison Transcripción de la llamada de resultados del tercer trimestre de 2026 de Avery Dennison Benzinga 2026.10.29 15:58 (GMT+0) Open on Benzinga Other news Ascent Industries Q3 EPS $0.15 Up From $(0.01) YoY, Sales $27.135M Up From $19.697M YoY Agilon Health Q3 EPS $1.97 Beats $(1.46) Estimate, Sales $1.519B Beat $1.461B Estimate UPDATE: Edwards Lifesciences Raises FY2026 Adj EPS Guidance from $2.95-$3.05 to $2.97-$3.05 vs $3.00 Est; Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est Accuray Announces 1-For-40 Reverse Stock Split, Effective Nov. 9 Enact Holdings Q3 Adj. EPS $1.19 Beats $1.18 Estimate, Sales $312.854M Miss $317.921M Estimate Maravai LifeSciences Raises FY2026 Sales Guidance from $205.000M-$215.000M to $212.000M-$216.000M vs $211.767M Est
UPDATE: Edwards Lifesciences Raises FY2026 Adj EPS Guidance from $2.95-$3.05 to $2.97-$3.05 vs $3.00 Est; Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est
Maravai LifeSciences Raises FY2026 Sales Guidance from $205.000M-$215.000M to $212.000M-$216.000M vs $211.767M Est
